COVID-19 has no impact on disease activity, progression and cognitive performance in people with mul...
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundSequelae of COVID-19 in people with multiple sclerosis (PwMS) have not been characterised. We explored whether COVID-19 is associated with an increased risk of disease activity, disability worsening, neuropsychological distress and cognitive dysfunction during the 18–24 months following SARS-COV-2 infection.MethodsWe enrolled 174 PwMS wit...
Alternative Titles
Full title
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2880105136
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2880105136
Other Identifiers
ISSN
0022-3050,1468-330X
E-ISSN
1468-330X
DOI
10.1136/jnnp-2023-332073
